The purpose of this transmittal is to inform District of Columbia (DC) Medicaid Providers that effective January 1, 2020, the Department of Health Care Finance (DHCF) is eliminating the $1.00 co-pay for Medication Assisted Treatment (MAT) drug products used to treat substance use disorders (SUD) for all Fee for Service (FFS) Medicaid beneficiaries.
dhcf
Department of Health Care Finance - DHCF
Attention DC Medicaid and Alliance Beneficiaries: Please click here to get information on the recent DHCF data incident.
- Home
- Services
- District Health Care Coverage
- Long Term Care Admin
-
Providers
- Information for Doula Providers
- Important Notice for Primary Care Providers
- Alliance Program Changes-Providers
- Conflict-Free Case Management
- Division of Program Integrity (DPI)
- Medicaid Program Integrity
- Person-Centered Planning
- Provider Information and Forms
- Provider Performance
- Rates and Reimbursements
- Telemedicine
- Innovation
- Innovation
- Policies
- Ombudsman
-
About
- DC Medical Care Advisory Committee
- Beneficiary Advisory Council
- Meet Our Executive Team
- Publications and Forms
- Americans with Disabilities Act Information
- Grievances/Appeals
- Open Government and FOIA - DHCF
- Procurement Opportunities
- Grant Opportunities
- Director's Biography
- HIPAA - Notice of Privacy Practice
- DHCF Notice of Non-Discrimination and Accessibility Requirements Statement
- Innovation Initiatives
- Managed Care Quality Strategy
- Maternal Health Projects
- Perinatal Mental Health Task Force